Forskolin, by elevating cAMP levels, broadly tunes cellular responses, potentially affecting proteins such as C17orf50 by altering the phosphorylation state of cellular proteins. Similarly, Isoproterenol and db-cAMP, through their effects on cAMP, prepare the cellular milieu for a state where proteins like C17orf50 could be modulated. PMA, known for its role in activating protein kinase C, impacts a wide range of cellular functions which could extend to proteins indirectly associated with this pathway. In the same vein, Ionomycin, by increasing calcium concentrations within cells, triggers a cascade of calcium-dependent signaling events that can have far-reaching implications for numerous proteins. Insulin, a key regulator of metabolic processes, sets off a complex signaling network that has the capacity to influence diverse proteins, potentially including C17orf50.
The activity of C17orf50 could also be influenced by chemicals that modify gene expression. Retinoic acid and 5-Azacytidine, by altering transcriptional activity, can change the cellular complement of proteins, thereby affecting those like C17orf50. Retinoic acid acts through its receptors to modulate gene expression, while 5-Azacytidine inhibits DNA methyltransferases, which could lead to the upregulation of proteins that are typically silenced. Sodium butyrate further extends this theme by inhibiting histone deacetylases, thereby changing chromatin structure and potentially influencing gene expression and protein function. Epidermal Growth Factor, as a critical growth signal, and Lithium chloride, through its influence on the phosphoinositide pathway, demonstrate how signaling molecules and simple ions can exert wide-ranging effects on cellular proteins. These chemicals, by affecting various signaling molecules and pathways, create a biochemical context that may permit the modulation of proteins like C17orf50, even in the absence of direct interaction.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Activates protein kinase C (PKC), which is involved in numerous signaling pathways, some of which may be relevant to C17orf50 function. | ||||||
Ionomycin, free acid | 56092-81-0 | sc-263405 sc-263405A | 1 mg 5 mg | $96.00 $264.00 | 2 | |
Increases intracellular calcium levels, influencing various calcium-dependent signaling pathways, potentially affecting C17orf50. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Activates the insulin receptor signaling pathway, which may interact with a wide array of cellular proteins and processes, possibly including C17orf50. | ||||||
Adenosine 3′,5′-cyclic monophosphate | 60-92-4 | sc-217584 sc-217584A sc-217584B sc-217584C sc-217584D sc-217584E | 100 mg 250 mg 5 g 10 g 25 g 50 g | $116.00 $179.00 $265.00 $369.00 $629.00 $1150.00 | ||
A second messenger that can activate protein kinase A (PKA) and may modulate pathways that C17orf50 is involved in. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
A membrane-permeable analog of cAMP that can activate PKA, potentially affecting signaling pathways involving C17orf50. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Modulates gene expression through retinoic acid receptors, which may alter the expression or function of proteins related to C17orf50. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
A DNA methyltransferase inhibitor that can alter gene expression patterns and may affect the expression of C17orf50. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
A beta-adrenergic agonist that increases intracellular levels of cAMP, possibly influencing C17orf50-related pathways. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Influences the phosphoinositide signaling pathway and may impact downstream proteins, potentially including C17orf50. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
A histone deacetylase inhibitor that can change the chromatin structure and influence gene expression, possibly affecting C17orf50. | ||||||